How to Administer Intralesional Triamcinolone in Oral Lichen Planus
For oral lichen planus, inject triamcinolone acetonide 10 mg/mL (diluted from 40 mg/mL) directly into or around the lesion using a tuberculin syringe with a 23-25 gauge needle, administering 0.5 mL per site at weekly intervals for 2-3 weeks. 1
Preparation and Equipment
Use triamcinolone acetonide at 10 mg/mL concentration for oral lesions 1. The FDA-approved Kenalog-10 formulation is specifically indicated for intralesional use in lichen planus 1. If using the 40 mg/mL concentration, dilute it with sterile normal saline to achieve 10 mg/mL 2.
Essential equipment:
Shake the vial before use to ensure uniform suspension. Inspect for clumping or granular appearance (agglomeration) - if present, discard the vial 1. After withdrawal, inject immediately to prevent settling in the syringe 1.
Injection Technique
Inject directly into the lesion - either intradermally or submucosally 1. The goal is perilesional/intralesional placement, meaning into and around the affected tissue 3.
Dosing per site:
- Administer 0.5 mL per injection site 4
- Multiple sites separated by at least 1 cm may be injected 1
- Total dose should not exceed 20 mg per session 5
Critical technical points:
- Carefully consider injection site and volume due to potential for cutaneous atrophy 1
- Avoid intravascular injection by aspirating before injecting 6
- Apply antiseptic measures and consider tamponade of salivary orifices 6
- Ethyl chloride spray may be used to reduce injection discomfort 1
Treatment Schedule
Inject at weekly intervals 1, 6, 7. The evidence supports:
- 2-3 injections for minor lesions (affecting limited areas) 7
- 3 injections for major lesions (extensive involvement) 7
- Continue until complete response is achieved 4
Most patients show complete response after 2-6 injections, with papular or reticular forms responding faster than erosive forms 6. One high-quality study demonstrated 84.4% complete response in ulcerative oral lichen planus after 1-2 injections 4.
Expected Outcomes and Follow-up
Rapid symptom relief occurs within 1 week 4. Complete healing of erosive lesions typically occurs within 2-3 weeks for minor lesions and 3 weeks for major lesions 7. However, the 2024 NCCN guidelines note that intralesional triamcinolone is used as an adjunctive treatment option for lichen planus, particularly for localized lesions 8.
Important caveat: Recurrence is common. Studies show relapse rates of 74% without adjunctive therapy 9, with recurrence typically occurring 4-6 months after treatment 6. When recurrence occurs, 1-2 additional injections usually resolve symptoms 6. One study showed complete response patients experienced recurrence after 3-24 months (mean 12 months) 7.
Combination Therapy Considerations
The 2024 NCCN guidelines recommend intralesional triamcinolone as part of a broader treatment approach, not as monotherapy 8. Recent evidence suggests combining triamcinolone with hyaluronic acid significantly reduces recurrence rates from 74.1% to 11.1% 9. The most recent 2026 research indicates that micro-needle assisted delivery of triamcinolone plus hyaluronic acid shows superior outcomes compared to topical application alone 10.
For optimal results, consider combining intralesional injections with:
- High-potency topical corticosteroids (clobetasol 0.05%) for maintenance 8
- Oral prednisolone for extensive disease (25-30 mg daily for major lesions, 15-20 mg for minor lesions, both for 2 weeks) 7
Contraindications and Precautions
Do not inject:
- At sites of active infection (impetigo, herpes) 2
- In patients with hypersensitivity to triamcinolone 2
- Large volumes in patients with active tuberculosis or systemic fungal infection 2
Monitor for adverse effects:
- Local atrophy (most common concern with intralesional steroids) 1
- Pigmentary changes and telangiectasias 2
- Repeated injections can suppress the hypothalamic-pituitary-adrenal axis 2
The formulation contains benzyl alcohol as a preservative, which may rarely cause contact allergic dermatitis 2, 1.